Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,240,610 papers from all fields of science
Search
Sign In
Create Free Account
DVL1P1 gene
Known as:
dishevelled segment polarity protein 1 pseudogene 1
, DISHEVELLED, DROSOPHILA, HOMOLOG-LIKE
, DVL-22
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
DVL2 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Abstracts from the 12 th meeting of the International Society for Neural Transplantation and Restoration
A. Álvarez-Buylla
,
Luis Azmitia
,
P. Capetian
,
M. Klett
,
M. Döbrössy
,
G. Nikkhah
2014
Corpus ID: 14732178
s from the 12th meeting of the International Society for Neural Transplantation and Restoration NeuroReport 2014, 25:139–163 Note…
Expand
2003
2003
District court affirms CMS's hold-harmless policy for DSH.
C. Keough
,
Gregory N. Etzel
Healthcare financial management : journal of the…
2003
Corpus ID: 46475722
Under CMS's hold-harmless policy, a hospital's Medicaid proxy for periods prior to 2000 may include certain state-only program…
Expand
1993
1993
[Delayed hypersensitivity and the primary antibody reaction after administration of infectious bovine rhinotracheitis inactivated oil vaccine to calves premedicated with glucan].
Š. Paulík
,
V. Bajová
,
G. Benko
Veterinární Medicína
1993
Corpus ID: 20037252
The level of delayed skin hypersensitivity (DSH) to DNFB and of the primary immune reaction was evaluated in the calves immunized…
Expand
1991
1991
CHANGES IN BLOOD PRESSURE AND FETAL DEVELOPMENT IN DOCA-SALT HYPERTENSIVE PREGNANT RATS
K. Sugahara
1991
Corpus ID: 76622134
In this study, DOCA-salt hypertensive (DSH) rats were used as the experimental model of hypertension in pregnancy, and changes in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE